Searching…
Learn about KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph). Discover how they work, understand possible side effects, and …
2026年2月15日 · Keytruda is used to treat multiple cancers, including non-small cell lung cancer, melanoma, triple-negative breast cancer, head and neck cancers, ovarian cancer, bladder cancer, …
Pembrolizumab, sold under the brand name Keytruda, is a humanized monoclonal antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy to treat many types of cancer. [12][14] It is …
2026年2月11日 · Overview: Keytruda is used to treat many types of cancer. The medicine helps to turn on the body's immune system, so it can attack cancer cells. Common side effects of Keytruda include …
Healthcare professionals may find information on FDA-approved indications for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), …
2026年2月11日 · KEYTRUDA and KEYTRUDA QLEX are the first and only PD-1 inhibitors approved for adults with platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal carcinoma with …
2026年4月28日 · Keytruda (pembrolizumab) is an immunotherapy drug used to treat more than a dozen types of cancer. Rather than attacking cancer cells directly like chemotherapy does, it works by …
KEYTRUDA, in combination with pemetrexed and platinum chemotherapy, is indicated for the first-line treatment of patients with metastatic nonsquamous non-small cell lung cancer (NSCLC), with no...
2026年4月13日 · Keytruda Qlex is a subcutaneous formulation of pembrolizumab that offers a faster, more convenient alternative to IV administration with comparable efficacy.
2025年8月21日 · Keytruda is a brand-name infusion approved to treat several types of cancer. Learn about side effects, warnings, dosage, and more.
